Episode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic
Does Big Science have a bullying problem? Why did the FDA change its tune on China? And what's cooler than $100 billion?\n\nWe cover all that and more this week on \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We discuss the scandalous end of Eric Lander's tenure as presidential science adviser with STAT Washington correspondent Lev Facher and science writer Megan Molteni. Then we dive into the FDA's about-face on cancer drugs developed in China and what it means for the cost of medicine in the U.S. We also explain how Pfizer's record-setting year somehow disappointed Wall Street and explore whether it's a good idea to end mask mandates.